SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as the company nears the final data readout for its pivotal Phase 3 REGAL trial, having confirmed that 78 of the 80 required events for the study have been reached. The community is actively debating the potential for a significant short squeeze given the substantial short interest, while investors maintain a bullish outlook on the transformative clinical potential of the GPS treatment for AML patients.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is drawing significant investor attention ahead of its upcoming earnings report, with the community closely tracking its aggressive infrastructure buildout, including a newly broken-ground gigawatt-scale AI factory. Market participants are debating the company's valuation and capital expenditure intensity, while bullish sentiment is fueled by its strategic positioning within the AI hardware and cloud ecosystem.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy Enterprises is experiencing significant volatility and community debate as investors weigh strong operational milestones, such as record battery production and a major new energy storage joint venture, against concerns regarding potential share dilution and outstanding legal class actions. While some retail traders are betting on a short squeeze fueled by high short interest and emerging data center demand, others remain cautious, advising a wait-and-see approach until management demonstrates consistent earnings execution.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is facing intense volatility as shareholders react to a significant public offering priced at a discount to market levels. While some investors express frustration over the timing and dilutive nature of the raise, others are debating whether the capital influx positions the company to aggressively scale production and pursue strategic M&A within the high-demand defense drone sector.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba Group is drawing significant investor interest as the market closely monitors potential trade and AI-focused discussions between U.S. and Chinese leadership. While community sentiment is heavily polarized between long-term bulls betting on cloud and AI infrastructure growth and skeptics worried about earnings performance, the stock remains a central point of debate regarding its valuation as a strategic AI player.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed is experiencing significant volatility and trending higher as investors speculate on a short squeeze, fueled by high short interest and institutional accumulation following a major restructuring. Community sentiment remains deeply divided between those betting on a long-term turnaround in silicon carbide demand for AI data centers and those skeptical due to the company's past bankruptcy and share dilution history.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is experiencing a surge in trading activity as investors speculate on a potential take-private bid from Nelson Peltz's Trian Fund Management. The community is actively discussing the stock's significant short interest and valuation relative to its sector, with many traders holding for a potential squeeze or buyout announcement.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as investors weigh strong commercial execution against persistent uncertainty regarding the CMS appeals process, with the stock recently experiencing volatility alongside high-volume activity. Community discussion remains polarized, focusing on a mix of cautious optimism over revenue growth potential and frustration with recent price action, while monitoring for any signs of potential M&A activity.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing intense bullish momentum and gamma squeeze activity as investors capitalize on its role in edge AI and defense infrastructure, with the community drawing parallels to the rapid growth trajectories of other major memory players. While some warn of volatility following a recent parabolic rally and pending patent litigation, bulls are aggressively accumulating on dips, driven by the belief that its radiation-hardened memory tech is essential for next-generation data centers and aerospace projects.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines is trending as investors react to a recent capital raise and aggressive production expansion aimed at meeting surging demand for U.S.-made drone components. Community discussions are highly polarized, with some bulls highlighting the company's position in domestic defense programs, while vocal critics express concern over stock dilution and the company's recent price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$GRFS Grifols rallies after board approves IPO of U.S. Biopharma business 
 
Grifols says its Strategy Committee has proposed, and the board has approved, the initial public offering on the U.S. stock market of a portion of the shares of the company&#39;s U.S. Biopharma business. If the transaction is successfully completed, Grifols would float a minority stake in Grifols&#39; Biopharma U.S. The parent company, Grifols S.A., would maintain its listing in Spain and would retain control of the U.S. business.  
 
The proposed IPO is intended to raise capital to &quot;support the company&#39;s strategic priorities, including debt reduction and investment in growth across key markets where it is advancing its self-sufficiency projects.&quot; Grifols says it will continue to grow its plasma and diagnostics businesses in other markets, &quot;with improved profit margins from our self-sufficiency programs in Egypt and Canada and growing revenues from new products.&quot; Shares of Grifols are up 6% to $8.05 in premarket trading.

StockTwits Web

Grifols, SA

 Grifols rallies after board approves IPO of U.S. Biopharma business 
 
Grifols says its Strategy Committee has proposed, and the board has approved, the initial public offering on the U.S. stock market of a portion of the shares of the company's U.S. Biopharma business. If the transaction is successfully completed, Grifols would float a minority stake in Grifols' Biopharma U.S. The parent company, Grifols S.A., would maintain its listing in Spain and would retain control of the U.S. business.  
 
The proposed IPO is intended to raise capital to "support the company's strategic priorities, including debt reduction and investment in growth across key markets where it is advancing its self-sufficiency projects." Grifols says it will continue to grow its plasma and diagnostics businesses in other markets, "with improved profit margins from our self-sufficiency programs in Egypt and Canada and growing revenues from new products." Shares of Grifols are up 6% to $8.05 in premarket trading.